Key Takeaways
- Arm Holdings (ARM) shares reached a record $239.51 before advancing to $242.03, marking a year-to-date surge exceeding 104%.
- Wall Street firms including Rosenblatt and Jefferies boosted price targets to $270 and $290 respectively, maintaining Buy recommendations following impressive Q4 results.
- The company reported 29% year-over-year licensing revenue growth and an 11% increase in royalties, totaling $1.49 billion in quarterly revenue.
- Bernstein launched coverage with an Outperform rating and $300 target, highlighting the emerging “CPU renaissance” opportunity.
- Several law firms disclosed preliminary securities-fraud investigations related to potential U.S. antitrust concerns over ARM’s licensing practices.
Arm Holdings reached an unprecedented peak of $239.51 during Tuesday’s trading session before extending gains to $242.03, propelling its 2026 performance to more than double with gains surpassing 104%.
Arm Holdings plc American Depositary Shares, ARM
The rally followed impressive quarterly results released in early May. The company’s licensing division saw revenue surge 29% compared to the prior year, while royalty income expanded 11%. Total quarterly revenue reached $1.49 billion.
These strong financials triggered a cascade of upward revisions from Wall Street. Rosenblatt Securities elevated its price objective from $175 to $270. TD Cowen increased its forecast from $165 to $265. Jefferies made an even more aggressive adjustment, raising its target from $210 to $290 based on anticipated growth in artificial general intelligence CPU demand.
The most bullish projection emerged from Sanford C. Bernstein, which launched coverage with an Outperform recommendation and a $300 price target. The research firm believes ARM is positioned to capitalize on what it describes as a “renaissance of CPUs,” predicting substantial expansion in the server CPU market throughout the coming years.
Wall Street’s View
Among 27 analysts tracking the company, 20 maintain Buy ratings, six recommend Hold, and one advises Sell. The average price target currently stands at $203.79, though this consensus lags considerably behind recent projections from optimistic analysts.
Citigroup shares the positive outlook on server CPU expansion, forecasting that agentic CPUs could generate $59.4 billion in market value by decade’s end.
ARM’s market capitalization currently ranges between approximately $235 billion and $247 billion depending on intraday fluctuations, with shares trading at a price-to-earnings ratio between 253 and 265. InvestingPro analysis indicates the stock appears overvalued compared to its Fair Value calculation.
Partners Group Holding AG initiated a position in ARM during the fourth quarter, acquiring 7,300 shares worth roughly $798,000. Institutional ownership accounts for 7.53% of outstanding shares.
Potential Concerns
Despite the momentum, some challenges have emerged. Several law firms have launched preliminary securities-fraud investigations following media reports about potential U.S. antitrust examination of ARM’s licensing structure. No formal allegations have been made, and these inquiries remain in exploratory phases.
CEO Rene Haas divested 9,299 shares on April 14th at an average of $160.85 per share through a predetermined Rule 10b5-1 trading arrangement. Insider William Abbey similarly sold 7,000 shares on May 15th at $212.55, with both transactions reportedly executed to satisfy tax obligations on vested equity compensation.
A separate industry analysis revealed that both AMD and ARM captured additional server CPU market share, while Intel’s portion declined from 59% to 55%. Evercore cited this data when maintaining Outperform recommendations across all three companies.
ARM and SoftBank Group reportedly made a preliminary acquisition proposal for Cerebras Systems before its anticipated public offering. Cerebras rejected the approach.
The stock’s trading range over the past 52 weeks spans from $100.02 to $239.50, with the 50-day moving average positioned at $168.98.





